CORDIS
EU research results

CORDIS

English EN
Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by Selective Reagentless Process

Removal and Recovery of Pharmaceutical Persistent Pollutants from Wastewater by Selective Reagentless Process

Objective

Pharmaceutical drugs, characterized by their environmental persistence (e.g. cytostatic drugs [CDs]) have been detected in water bodies (drinking water, groundwater, surface water, and effluent wastewater) at concentrations up to μg/L level. Actual methods for the removal and degradation of CDs, including electrochemical, photochemical, and biological methods have been developed. However, these methods are expensive and sometimes inefficient for CDs complete removal from the treated water. Including the exploitation of previous results from EU funded projects, the goal of project RECOPHARMA is to design, develop, validate and demonstrate a novel process by sequential integration the potentials offered by Molecular Imprinted Polymers (MIPs), Reagentless Thermosorption (RTS), Nanocomposites Functional Materials, Advanced Oxidation Processes, for an effective treatment aiming the recovery of target recalcitrant CDs and degradation of corresponding transformation products or metabolites, working in a continuous operation mode. The suggested approach offers versatile, fast, highly efficient, and low-cost treatment for wastewaters.

RECOPHARMA brings together academic research centres and the private sector, with a long-term goal of designing and developing advanced water treatment technologies in the interest of the society and integrate them for demonstration following a circular economy approach. Through the scheduled secondments, the involved staff will perform the required R&I to demonstrate the technical and economic feasibility of the developed process, including the technical formation of specialists as a fundamental activity to project success. The secondments will also enhance the exchange of knowledge, best practices, know-how, innovations, experience, mutual cooperation and culture of work between different organizations, regions and countries through the partners’ well-established reputation as transfer hubs.
Leaflet | Map data © OpenStreetMap contributors, Credit: EC-GISCO, © EuroGeographics for the administrative boundaries

Coordinator

UNIVERSITAT AUTONOMA DE BARCELONA

Address

Campus De La Uab Bellaterra
08193 Cerdanyola Barcelona

Spain

Activity type

Higher or Secondary Education Establishments

EU Contribution

€ 270 000

Participants (5)

Sort alphabetically

Sort by EU Contribution

Expand all

LUNDS UNIVERSITET

Sweden

EU Contribution

€ 171 000

UNIVERSITE DE PAU ET DES PAYS DE L'ADOUR

France

EU Contribution

€ 153 000

UNIVERSITA DEGLI STUDI DI UDINE

Italy

EU Contribution

€ 171 000

AERIS TECNOLOGIAS AMBIENTALES SL

Spain

EU Contribution

€ 63 000

EUROPE FOR BUSINESS LTD

United Kingdom

EU Contribution

€ 67 500

Partners (2)

Sort alphabetically

Expand all

UNIVERSIDAD DE LA HABANA

CENTRO DE INVESTIGACION Y DESARROLLO DE MEDICAMENTOS

Project information

Grant agreement ID: 778266

Status

Ongoing project

  • Start date

    1 January 2018

  • End date

    31 December 2021

Funded under:

H2020-EU.1.3.3.

  • Overall budget:

    € 895 500

  • EU contribution

    € 895 500

Coordinated by:

UNIVERSITAT AUTONOMA DE BARCELONA

Spain